From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery

From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery

SHANGHAI, May 27, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated Screening & Chemistry." Moderated by Victoria...

HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases

HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases

Company enters into new agreement with the Gates Foundation to identify novel drug leads targeting tuberculosis and malaria and new agents for non-hormonal contraception. CHENGDU, China, Nov. 20, 2025 /PRNewswire/ -- Shanghai Stock Exchange listed...

menu
menu